# Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression

> **NCT02321436** · PHASE4 · COMPLETED · sponsor: **Ipsen** · enrollment: 42 (actual)

## Conditions studied

- Stroke
- Upper Limb Spasticity

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02321436
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02321436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02321436, "Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02321436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*